Results: 5

Cost-effectiveness of rotavirus vaccination in Mozambique

Vaccine; 40 (36), 2022
Introduction: Rotavirus is one of the most common cause of severe gastroenteritis in children, with the largest mortality burden in low- and middle-income countries. To prevent rotavirus gastroenteritis, Mozambique introduced ROTARIX vaccine in 2015, however, its cost-effectiveness has never been establi...

Adaptation of WHO's generic tuberculosis patient cost instrument for a longitudinal study in Africa

Global health action; 14 (1), 2021
The WHO developed a generic 'TB patient cost survey' tool and a standardized approach to assess the direct and indirect costs of TB incurred by patients and their households, estimate the proportion of patients experiencing catastrophic costs, and measure the impact of interventions to reduce patient cos...

Impact and Cost of the HIV/AIDS National Strategic Plan for Mozambique, 2015-2019--Projections with the Spectrum/Goals Model

PLos ONE; 10 (11), 2015
Mozambique continues to face a severe HIV epidemic and high cost for its control, largely born by international donors. We assessed feasible targets, likely impact and costs for the 2015-2019 national strategic HIV/AIDS plan (NSP). Methods: The HIV epidemic and response was modelled in the Spectrum/Goal...

The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis

PloS med; 11 (9), 2014
Background: Point-of-care CD4 tests at HIV diagnosis could improve linkage to care in resource-limited settings. Our objective is to evaluate the clinical and economic impact of point-of-care CD4 tests compared to laboratory-based tests in Mozambique. Methods and findings: We use a validated model of HIV...